Filing Details

Accession Number:
0001127602-18-026463
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-29 16:37:49
Reporting Period:
2018-08-27
Accepted Time:
2018-08-29 16:37:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741853 Kevin Hourican One Cvs Drive
Woonsocket RI 02895
Evp & President, Cvs Pharmacy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-27 4,426 $54.53 12,135 No 4 M Direct
Common Stock Disposition 2018-08-27 8,564 $75.00 3,571 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2018-08-27 4,426 $0.00 4,426 $54.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-04-01 2020-04-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock (Restricted) 10,584 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $74.29 2015-04-01 2021-04-01 9,442 9,442 Direct
Common Stock Stock Option $102.26 2016-04-01 2022-04-01 17,822 17,822 Direct
Common Stock Stock Option $104.82 2017-04-01 2023-04-01 17,611 17,611 Direct
Common Stock Stock Option $78.05 2018-04-03 2024-04-03 30,169 30,169 Direct
Common Stock Stock Option $62.21 2019-04-01 2025-04-01 87,575 87,575 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-01 9,442 9,442 Direct
2022-04-01 17,822 17,822 Direct
2023-04-01 17,611 17,611 Direct
2024-04-03 30,169 30,169 Direct
2025-04-01 87,575 87,575 Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan.
  2. Option became exercisable in four equal annual installments beginning on 4/1/2014.
  3. Option became exercisable in four equal annual installments beginning on 4/1/2015.
  4. Option became exercisable in four equal annual installments beginning on 4/1/2016.
  5. Option became exercisable in four equal annual installments beginning on 4/1/2017.
  6. Option became exercisable in four equal annual installments beginning on 4/3/2018.
  7. Option becomes exercisable in four equal annual installments beginning on 4/1/2019.